SS
CUE icon

Sunbelt Securities’s Cue Biopharma CUE Stock Holding History

Sunbelt Securities’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8
Closed -$170 – 2825
2025
Q3 		$170 Hold
8
– – ﹤0.01% 2437
2025
Q2 		$258 Hold
8
– – ﹤0.01% 1737
2025
Q1 		$216 Hold
8
– – ﹤0.01% 1739
2024
Q4 		$242 Hold
8
– – ﹤0.01% 1745
2024
Q3 		$179 Hold
8
– – ﹤0.01% 1795
2024
Q2 		$294 Hold
8
– – ﹤0.01% 1687
2024
Q1 		$448 Hold
8
– – ﹤0.01% 1635
2023
Q4 		$626 Hold
8
– – ﹤0.01% 1582
2023
Q3 		$545 Hold
8
– – ﹤0.01% 1645
2023
Q2 		$865 Hold
8
– – ﹤0.01% 1544
2023
Q1 		$839 Buy
+8
New +$763 ﹤0.01% 1510

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Sunbelt Securities's CUE Position: Q4 2025 in Review

Sunbelt Securities sold out of Cue Biopharma (CUE) in Q4 2025, closing a stake of 8 shares — an estimated $170 sold.

Sunbelt Securities first reported a position in CUE in Q1 2023 and held it in 11 quarters. The position peaked at $865 in Q2 2023. 47 funds tracked by Wall St. Rank hold CUE as of Q4 2025.

  • Sunbelt Securities reported no remaining Cue Biopharma position as of Q4 2025 after selling out during the quarter.
  • Sunbelt Securities sold 8 Cue Biopharma shares in Q4 2025, an estimated $170.
  • Sunbelt Securities first reported a position in Cue Biopharma in Q1 2023 and held it in 11 quarters.
  • Sunbelt Securities's Cue Biopharma position peaked at $865 in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2025.

Based on Sunbelt Securities's 13F filing for Q4 2025, filed 20 Feb 2026.